You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 24, 2025

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
1Université Paris Cité, Assistance publique-Hôpitaux de Paris, hôpital Saint-Louis, service hématologie seniors, 1, avenue Claude-Vellefaux, 75010 Paris, France.
Myelodysplastic syndromes (MDS) are stem cell diseases affecting the elderly. New drugs targeting MDS biology are being tested with hypomethylating agents (HMA) to improve outcomes and prevent acute myeloid leukemia.
Area of Science: